OXYNORMORO 20 mg, comprimé orodispersible — plaquette(s) thermoformée(s) aluminium polyamide PVC-Aluminium de 14 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400938042887 -
CIP7
3804288 -
CIS
61115864
What the source publishes
- Holder
- MUNDIPHARMA
- Active ingredients
- CHLORHYDRATE D'OXYCODONE, OXYCODONE
- Form
- comprimé orodispersible
- Package
- plaquette(s) thermoformée(s) aluminium polyamide PVC-Aluminium de 14 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription limitée à 4 semaines ; prescription en toutes lettres sur ordonnance sécurisée ; stupéfiants
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2007-07-16
- Prescription
- Prescription or restricted
Names this record is found by
- OXYNORMORO 20 mg, comprimé orodispersible — plaquette(s) thermoformée(s) aluminium polyamide PVC-Aluminium de 14 comprimé(s)
- OXYNORMORO 20 mg, comprimé orodispersible
- CHLORHYDRATE D'OXYCODONE
- OXYCODONE
Complete source data
{
"cis": "61115864",
"cip7": "3804288",
"form": "comprimé orodispersible",
"name": "OXYNORMORO 20 mg, comprimé orodispersible — plaquette(s) thermoformée(s) aluminium polyamide PVC-Aluminium de 14 comprimé(s)",
"cip13": "3400938042887",
"holder": "MUNDIPHARMA",
"routes": [
"orale"
],
"holders": [
"MUNDIPHARMA"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "5.82",
"authorisedOn": "2007-07-16",
"compositions": [
{
"name": "CHLORHYDRATE D'OXYCODONE",
"nature": "SA",
"strength": "20,00 mg",
"linkageNumber": "1",
"substanceCode": "05087",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "OXYCODONE",
"nature": "FT",
"strength": "18,00 mg",
"linkageNumber": "1",
"substanceCode": "46704",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription limitée à 4 semaines ; prescription en toutes lettres sur ordonnance sécurisée ; stupéfiants",
"dispensingFee": "1.02",
"medicinePrice": "4.80",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "OXYNORMORO 20 mg, comprimé orodispersible",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) thermoformée(s) aluminium polyamide PVC-Aluminium de 14 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2009-10-05",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE D'OXYCODONE",
"OXYCODONE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"prescription limitée à 4 semaines",
"prescription en toutes lettres sur ordonnance sécurisée",
"stupéfiants"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- douleurs cancéreuses sévères<br>- douleurs sévères neuropathiques<br>- traitement des fortes douleurs de l'arthrose du genou ou de la hanche et de la lombalgie chronique, en dernier recours, lorsque les solutions chirurgicales sont envisagées ou que la pose de prothèses orthopédiques est contre-indiquée ou refusée par le malade ; JOURNAL OFFICIEL ; 13/04/16",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400938042887"